E.O. Wilson Biodiversity Foundation Names New Half-Earth Chair
April 23, 2024 11:08 ET
|
E.O. Wilson Biodiversity Foundation
The E.O. Wilson Biodiversity Foundation has named Dr. Alessandro Catenazzi as its new Half-Earth Chair.
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
April 16, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the...
V-me TV Unveils Exciting New Prime Time Lineup for April
April 15, 2024 09:24 ET
|
Vme TV
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) -- V-me TV, the vibrant and leading television network catering to the U.S. Hispanic audience, is thrilled to announce the launch of its new prime time lineup....
Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
April 11, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
PV-10 demonstrated significant anti-tumor activity in vivo in head and neck cancers KNOXVILLE, TN, April 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the...
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
April 08, 2024 11:36 ET
|
Revolution Medicines, Inc.
Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in...
Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
March 27, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
New Provectus Spinout Company Would Commercialize Combination Therapy of University’s Light Source Medical Device and Provectus’s Pharmaceutical-Grade Rose Bengal Sodium KNOXVILLE, TN, March 27,...
Inventaire botanique du nouveau parc Agguttinni : Une référence pour la conservation du Nunavut
March 12, 2024 13:30 ET
|
Musée canadien de la nature
OTTAWA, 12 mars 2024 (GLOBE NEWSWIRE) -- Une équipe de botanistes du Musée canadien de la nature, sous la baguette de Mme Lynn Gillespie, Ph. D., vient de dresser un inventaire détaillé de la flore...
A botanical baseline for conservation of Agguttinni, Nunavut’s largest and newest territorial park
March 12, 2024 13:30 ET
|
Canadian Museum of Nature
Canadian Museum of Nature botanists have completed a comprehensive study of the plant diversity of Agguttinni, Nunavut's newest territorial park.
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
March 12, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...
Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
March 07, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
Moffitt’s preclinical findings strongly suggest PV-10 induces immunogenic cell death-associated immunogenicity in HPV-positive and HPV-negative HNSCC in vitro and in vivo KNOXVILLE, TN, March 07,...